[1] TORRE L A,BRAY F,SIEGEL R L,et al. Global cancer statistics,2012[J]. CA Cancer J Clin,2015,65(2):87-108.[2] DIDKOWSKA J,WOJCIECHOWSKA U,MANCZUK M,et al. Lung cancer epidemiology:contemporary and future challenges worldwide[J]. Ann Transl Med,2016,4(8):150.[3] TAKAHASHI-YANAGA F,KAHN M. Targeting Wnt signaling:can we safely eradicate cancer stem cells?[J]. Clin Cancer Res,2010,16(12):3153-3162.[4] KOURY J,ZHONG L,HAO J. Targeting signaling pathways in cancer stem cells for cancer treatment[J]. Stem Cells Int, 2017,2017:2925869.[5] STEWART D J,CHANG D W,YE Y,et al. Wnt signaling pathway pharmacogenetics in non-small cell lung cancer[J]. Pharmacogenomics J,2014,14(6):509-522.[6] CHEN B,DODGE M E,TANG W,et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer[J]. Nat Chem Biol,2009,5(2):100-107.[7] MO M L,LI M R,CHEN Z,et al. Inhibition of the Wnt palmitoyltransferase porcupine suppresses cell growth and downregulates the Wnt/beta-catenin pathway in gastric cancer[J]. Oncol Lett,2013,5(5):1719-1723.[8] FREWER K A,SANDERS A J,OWEN S,et al. A role for WISP2 in colorectal cancer cell invasion and motility[J]. Cancer Genomics Proteomics,2013,10(4):187-196.[9] REYA T,CLEVERS H. Wnt signalling in stem cells and cancer[J]. Nature,2005,434(7035):843-850.[10] MACDONALD B T,TAMAI K,HE X. Wnt/beta-catenin signaling:components,mechanisms,and diseases[J]. Dev Cell,2009,17(1):9-26.[11] PACHECO-PINEDO E C,DURHAM A C,STEWART K M,et al. Wnt/beta-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium[J]. J Clin Invest,2011, 121(5):1935-1945.[12] PRAKASH S,SWAMINATHAN U. beta catenin in health:A review[J]. J Oral Maxillofac Pathol,2015,19(2):230-238.[13] SU N,WANG P,LI Y. Role of Wnt/beta-catenin pathway in inducing autophagy and apoptosis in multiple myeloma cells[J]. Oncol Lett,2016,12(6):4623-4629.[14] GONZALEZ D M,MEDICI D. Signaling mechanisms of the epithelial-mesenchymal transition[J]. Sci Signal,2014, 7(344):re8.[15] BERNAUDO S,SALEM M,QI X,et al. Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/beta-catenin signaling[J]. Oncogene,2016,35(36):4816-4827.[16] TAKIGAWA H,KITADAI Y,SHINAGAWA K,et al. Mesenchymal stem cells induce epithelial to mesenchymal transition in colon cancer cells through direct cell-to-cell contact[J]. Neoplasia,2017,19(5):429-438.[17] YUAN X,WU H,HAN N,et al. Notch signaling and EMT in non-small cell lung cancer:biological significance and therapeutic application[J]. J Hematol Oncol,2014,7:87.[18] LIU Y,QIN Z,YANG K,et al. Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/beta-catenin signaling[J]. Oncol Rep,2017,37(3):1521-1528.[19] MASSZI A,FAN L,ROSIVALL L,et al. Integrity of cell-cell contacts is a critical regulator of TGF-beta 1-induced epithelial-to-myofibroblast transition:role for beta-catenin[J]. Am J Pathol,2004,165(6):1955-1967. |